Nemiralisib
CAS: 1254036-71-9
Ref. 3D-EAC03671
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
Nemiralisib is a small molecule that inhibits the PD-L1 protein. It can be used to treat cancer and autoimmune diseases. Nemiralisib binds to the PD-L1 protein and prevents it from binding to its ligands, CD80 or CD86. This prevents the immune system from being suppressed by the PD-L1 protein and may enable an anti-PD-L1 therapy to induce tumor regression in patients with cancer. Nemiralisib has been shown to inhibit P-glycoprotein (Pgp) activity in vitro, which may result in drug interactions with other drugs that are substrates of this transporter. Nemiralisib has a terminal half life of approximately 6 hours, meaning that most of it will be eliminated from the body within 24 hours after administration. The chemical name for nemiralisib is 1-[3-(4-chlorophenyl)phenyl]-3-[2-(methylsulfonyl)phenyl]urea. The
Chemical properties
Technical inquiry about: 3D-EAC03671 Nemiralisib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
